Similar articles

• Can eniluracil improve 5-fluorouracil therapy?

  Diasio RB. Diasio RB. Clin Colorectal Cancer. 2002 May;2(1):53. doi: 10.1016/S1533-0028(11)70503-5. Clin Colorectal Cancer. 2002. PMID: 12453337 No abstract available.
• Estimation of dihydropyrimidine dehydrogenase activity: does it have a role in cancer therapy?

  Collie-Duguid ES, McLeod HL, Cassidy J. Collie-Duguid ES, et al. Ann Oncol. 2000 Mar;11(3):255-7. doi: 10.1023/a:1008346207695. Ann Oncol. 2000. PMID: 10811489 No abstract available.
• Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?

  Milano G, McLeod HL. Milano G, et al. Eur J Cancer. 2000 Jan;36(1):37-42. doi: 10.1016/s0959-8049(99)00211-7. Eur J Cancer. 2000. PMID: 10741292 Review.
• Inhibiting 5-fluorouracil breakdown: a broken down approach to 5-fluorouracil modulation.

  Schilsky RL. Schilsky RL. Clin Colorectal Cancer. 2002 May;2(1):51-2. doi: 10.1016/S1533-0028(11)70502-3. Clin Colorectal Cancer. 2002. PMID: 12453336 No abstract available.
• [Severe 5-fluorouracil toxicity in a woman treated for breast cancer with concurrent osteogenesis imperfecta and dehydrogenase deficiency].

  Beuzeboc P, Pierga JY, Lyonnet DS, Couturier J, Pouillart P. Beuzeboc P, et al. Bull Cancer. 1996 Apr;83(4):324-7. Bull Cancer. 1996. PMID: 8680084 Review. French.